CLINICAL - Concepts & Controversies in the Management of Short Stature
Track
:
CLINICAL
Program Code:
S31
Date:
Sunday, June 20, 2010
Time:
9:30 AM to 10:15 AM
EST
Location:
25ABC
SPEAKER
(S):
Nelly Mauras, MD, Nemours Children's Clin, Jacksonville, FL Disclosure: Study Investigator, Genentech, Inc.; Investigator, Pfizer, Inc.
David E. Sandberg, Ph.D., Univ of Michigan Med Sch, , Ann Arbor, MI Disclosure: Nothing to Disclose
David E. Sandberg, PhD is Associate Professor and Director of the Division of Child Behavioral Health in the Department of Pediatrics & Communicable Diseases at the University of Michigan. He obtained his doctorate in Psychology from Concordia University in Montreal, Canada and completed postdoctoral research fellowships at the University of Miami Medical School and at the College of Physicians & Surgeons of Columbia University. As a pediatric psychologist, Dr. Sandberg provides psychoeducational and behavioral health services to children and adolescents with endocrine disorders, in particular, conditions affecting linear growth or disorders of sex development (DSD). Dr. Sandberg’s research program is closely linked to his clinical service. He participated in the recent international consensus conference on Idiopathic Short Stature and aspects of the published document are informed by his research findings. Dr. Sandberg’s research group also examines the psychosocial management of persons born with DSD, and their families. He was one of 50 international experts who participated in the conference that produced the Consensus Statement on Management of Intersex Disorders published in 2006. His on-going research involves developing a psychoeducational treatment manual for clinicians caring for newborns with congenital adrenal hyperplasia identified by newborn screen, a decision aid for parents of newborns considering genital surgery for a DSD, and the creation of a series of health-related quality of life measures for DSD.